From relentless itching and painful flare-ups to sleepless nights and emotional exhaustion, eczema can take a serious toll on ...
After making a stop in Vancouver on their 2025 world tour behind The Hives Forever Forever the Hives, the Hives have now enlisted Aussie punks the Chats for a slate of additional North American dates ...
Vivid Seats is the New York Post's official ticketing partner. We may receive revenue from this partnership for sharing this content and/or when you make a purchase. Featured pricing is subject to ...
When we talked to “Howlin'” Pele Almqvist on the BV Interviews podcast, he told us that the band would be back in 2026 for an East Coast / Midwest tour with Aussie punks The Chats. (The Hives toured ...
You wake up with red welts on your arms. By evening, they’ve crept across your stomach, itching and burning like you’ve rolled in poison ivy. A few days later, they’re back again. When this cycle goes ...
Novartis received approval from the Food and Drug Administration for Rhapsido (remibrutinib), an oral treatment for adults with chronic spontaneous urticaria. Rhapsido is the first Bruton’s tyrosine ...
The FDA has approved a Novartis drug for chronic spontaneous urticaria (CSU), providing patients an oral treatment alternative to currently available injectable medications. The regulatory decision ...
Washington, DC, Oct. 01, 2025 (GLOBE NEWSWIRE) -- On this Urticaria Day (UDAY), the Asthma and Allergy Foundation of America (AAFA), We CU, and The Mast Cell Disease Society (TMS) aim to raise ...
Novartis has scored the FDA’s approval for a second BTK inhibitor that’s for a non-cancer indication, teeing off a potential competition with Sanofi down the line. The FDA has blessed Novartis’ ...
Scientists have discovered that pollen is a hidden source of natural medicine for honeybees. Symbiotic bacteria called Streptomyces produce antimicrobial compounds that fight deadly bee and plant ...
France's Sanofi said its Dupixent drug jointly developed with Regeneron advanced toward a new indication for chronic hives in the European Union, while the U.S. Food and Drug Administration extended ...